Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

322

HTML

3323

Figures (1-1)

375

Tables (1-6)

171

Sum=4191

Feb 6, 2012 (publication date) through Jul 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Pharmacol Ther. Feb 6, 2012; 3(1): 1-6
Published online Feb 6, 2012. doi: 10.4292/wjgpt.v3.i1.1

Table 2 Characteristics of patients whose Helicobacter pylori status was checked only by serological test

Citation: Yanai A, Sakamoto K, Akanuma M, Ogura K, Maeda S. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. World J Gastrointest Pharmacol Ther 2012; 3(1): 1-6
URL: https://www.wjgnet.com/2150-5349/full/v3/i1/1.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v3.i1.1